SEPTOLETE*16LOZENGES 3MG+1MG EUCAL

Septolete eucalyptus flavour 3 mg/1 mg lozenges
Benzydamine hydrochloride/cetylpyridinium chloride

What it is and what it is used for
Septolete eucalyptus flavour lozenges is an anti-inflammatory, analgesic and antiseptic medicine for local oral use. Septolete eucalyptus flavour disinfects the mouth and throat and reduces signs of throat inflammation such as pain, redness, swelling, burning and impaired function.

Septolete eucalyptus flavour is used in the anti-inflammatory, analgesic and antiseptic treatment of:
- irritations of the throat, mouth and gums;
- gingivitis and pharyngitis.

You should contact your doctor if you do not feel better or if you feel worse after 3 days.

What you need to know before taking the medicine
Do not take Septolete eucalyptus flavour
- if you are allergic to benzydamine hydrochloride, cetylpyridinium chloride or any of the other ingredients of this medicine (listed in paragraph 6);
- this medicine should not be used in children under 6 years of age because the pharmaceutical form is not suitable for this age group.

Warnings and precautions
Talk to your doctor or pharmacist before taking Septolete eucalyptus flavour.
Septolete eucalyptus flavour should not be used for more than 7 days. If symptoms worsen or do not improve after 3 days, or if other symptoms occur, such as fever, consult your doctor.

The use, especially if prolonged, of topical preparations can lead to sensitisation, in which case treatment should be discontinued.

Septolete eucalyptus flavour should not be used together with anionic compounds, such as those found for example in toothpastes, so it is recommended not to use the product immediately before or after brushing your teeth.

Children and adolescents
Septolete eucalyptus flavour should not be used in children under 6 years of age as the lozenges are not suitable for this age group.

Possible side effects
Like all medicines, this medicine can cause side effects although not everybody gets them.

Rare side effects (may affect up to 1 in 1,000 people):
- urticaria, increased skin reactivity to sunlight (photosensitivity);
- sudden and uncontrolled narrowing of the airways to the lungs (bronchospasm).

Very rare side effects (may affect up to 1 in 10,000 people):
- local irritation in the oral cavity, burning sensation in the oral cavity.

Not known (frequency cannot be estimated from the available data):
- allergic reaction (hypersensitivity): severe allergic reaction (anaphylactic shock), signs of which may include difficulty breathing, chest pain or tightness and/or feeling dizzy/fainting, severe skin itching or raised lumps on the skin, swelling of the face, lips, tongue and/or throat, which may be life-threatening;
- burning of the oral mucosa, loss of sensation (anaesthesia) of the oral mucosa.

These side effects are usually transient. However, if they occur, it is recommended to talk to your doctor or pharmacist.
By following the instructions in the package leaflet, you will reduce the risk of side effects.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.